• Skip to primary navigation
  • Skip to main content
  • Skip to footer
ElevateBio

ElevateBio

Powering the creation of cell & gene therapies at a speed the world deserves.

  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Events & Publications
    • Elevated Insights
  • Careers
  • Contact
  • Search
  • End-to-End Capabilities
    • End-to-End Capabilities Overview
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Services and Quality
    • Enabling Services
  • Technology Platforms
    • Technology Platforms Overview
    • Gene Editing
    • Induced Pluripotent Stem Cells (iPSCS)
    • RNA, Cell, Protein & Vector Engineering
  • Therapeutic Design & Approaches
    • Therapeutic Design & Approaches Overview
    • Ex Vivo Cell & Gene Therapies
    • In Vivo Gene Therapies
  • Partnering
    • Partnering Overview
    • Industry Partnerships
    • Academic Partnerships
  • About
    • About Overview
    • Our Story
    • Our Ecosystem
    • Our Team
    • Culture of Expedition
    • Careers
  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Publications
    • Elevated Insights
  • Careers
  • Contact
  • End-to-End Capabilities


    End-to-End Capabilities Overview

    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Services and Quality
    • Enabling Services
  • Technology Platforms


    Technology Platform Overview

    • Gene Editing
    • Induced Pluripotent Stem Cells (iPSCS)
    • RNA, Cell, Protein & Vector Engineering
  • Therapeutic Design & Approaches


    Therapeutic Design & Approaches Overview

    • Ex Vivo Cell & Gene Therapies
    • In Vivo Gene Therapies
  • Partnering
    • Partnering Overview
    • Industry Partnerships
    • Academic Partnerships
  • About
    • About Overview
    • Our Story
    • Our Ecosystem
    • Our Team
    • Culture of Expedition
    • Careers

Explore
More

  • cGMP Manufacturing and Automation
  • Process Development
  • Analytical Services and Quality
  • Enabling Services
Home/End-to-End Capabilities/Enabling Services

Enabling Services

Providing end-to-end expert support capabilities for cell and gene therapies.

// End-to-end
   Capabilities

Enabling Your Vision for the Future

We provide the scientific, technological, and regulatory expertise to innovate, develop, and accelerate life-transforming therapies. Our team of seasoned drug developers provides guidance and partners with you throughout every step of the development and manufacturing process, providing a variety of enabling services to advance your program.

Enabling Services

Regulatory CMC Support
Apheresis
Regulatory CMC Support

Regulatory CMC Support

We incorporate regulatory support at the very beginning of product development journey and through the entire clinal and commercialization lifecycle to ensure we meet regulatory standards. We provide support across a range of CMC activities to ensure product consistency and future success in your regulatory filings.

Apheresis

Apheresis

We can provide ‘needle to needle’ support for your products, including managing apheresis and incorporating it within your development and manufacturing process.

R&D

Supporting Your Drug Discovery and Clinical Development

We leverage our drug development experience to accelerate the design, manufacturing and development of your products, from discovery through clinical development.

Our Research & Development expertise includes:

  • icon rd 1 Discovery services, including: vector design, process development, and assay development
  • icon rd 2 Clinical development support, including: process scale up, cGMP clinical supply, assay development, qualification and validation, and release testing
  • icon rd 3 Protein engineering, including: the development of antigen receptors, binders, and endonucleases, enabled by our platform technologies

Our Technology Platforms

Our next-generation enabling technologies and platforms offer the potential to pursue a broad range of therapeutic designs and applications. With proprietary gene editing, iPSCs, and RNA, cell, protein, and vector technologies and the ability to combine them, we can power the entire cell and gene therapy industry.

Learn about our technology

Our Therapeutic Approaches

We are enabling the development of a range of ex vivo and in vivo cell and gene therapies, leveraging our in-house capabilities and expertise to design and develop an array of modalities.

Learn about our therapeutic designs

What’s New

All News & Pubs

// September 26, 2023

Kyverna Therapeutics and ElevateBio to Advance Kyverna’s Ingenui-T Cell Therapy Manufacturing

Read More about Kyverna Therapeutics and ElevateBio to Advance Kyverna’s Ingenui-T Cell Therapy Manufacturing

// May 24, 2023

ElevateBio Announces $401 Million Series D Financing to Further Accelerate Growth

Read More about ElevateBio Announces $401 Million Series D Financing to Further Accelerate Growth

Elevated Insights

Biotechnology: The Key to America’s Next Manufacturing Revolution

By Heidi Wagner, Global Head of Government Affairs, and Mike Paglia, Chief Operating Officer of ElevateBio BaseCamp

View Insight

Partner with ElevateBio®

Wherever you are in your cell and gene therapy product lifecycle, we can strengthen and accelerate the development of your transformative therapies with our enabling technologies unmatched manufacturing capabilities.

Work with Us

// Work with us

Footer

ElevateBio

Investors & Media

LinkedIn Twitter

© 2023 ElevateBio. All Rights Reserved.

Privacy & Cookie Policy

  • End-to-End Capabilities
  • Technology Platforms
  • Therapeutic Design & Approaches
  • Partnering
  • About
  • Investors & Media
  • Careers
  • Contact
MENU
  • End-to-End Capabilities
    • End-to-End Capabilities Overview
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Services and Quality
    • Enabling Services
  • Technology Platforms
    • Technology Platforms Overview
    • Gene Editing
    • Induced Pluripotent Stem Cells (iPSCS)
    • RNA, Cell, Protein & Vector Engineering
  • Therapeutic Design & Approaches
    • Therapeutic Design & Approaches Overview
    • Ex Vivo Cell & Gene Therapies
    • In Vivo Gene Therapies
  • Partnering
    • Partnering Overview
    • Industry Partnerships
    • Academic Partnerships
  • About
    • About Overview
    • Our Story
    • Our Ecosystem
    • Our Team
    • Culture of Expedition
    • Careers
  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Publications
    • Elevated Insights
  • Careers
  • Contact